MRNA Operating Cash Flow (Statement)
Moderna · Operating Cash Flow (Statement)
MRNA Operating Cash Flow (Statement)
Latest reported-$1.05Bperiod ending
MRNA TTM Cash from Operations (-$331.48M → -$1.05B)
TTM operating cash flow (statement)
High-resolution chart · PNG
MRNA operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -1,052,000,000 | |
| -1,445,000,000 | |
| -1,852,000,000 | |
| -1,978,000,000 | |
| -2,697,000,000 | |
| -3,052,000,000 | |
| -3,004,000,000 | |
| -3,207,000,000 | |
| -3,241,000,000 | |
| -2,882,000,000 | |
| -3,118,000,000 | |
| -2,078,000,000 | |
| -226,000,000 | |
| 993,000,000 | |
| 4,981,000,000 | |
| 6,629,000,000 | |
| 9,653,000,000 | |
| 13,412,000,000 | |
| 13,620,000,000 | |
| 11,574,289,000 | |
| 9,191,037,000 | |
| 5,104,162,000 | |
| 2,026,971,000 | |
| 666,909,000 | |
| -332,887,000 | |
| -421,232,000 | |
| -458,968,000 | |
| -454,215,000 | |
| -427,378,000 | |
| -363,407,000 | |
| -330,865,000 | |
| -342,772,000 | |
| -305,181,000 | |
| -349,900,500 | |
| -331,484,000 |